Picture EBD Group Asia Bio Partnering Forum 2024 Singapore 650x100px
Document › Details

Marinomed Biotech AG. (11/5/18). "Press Release: Marinomed Announces Its Intention to Launch an Initial Public Offering and Listing on the Vienna Stock Exchange [Not for US, AU, CA, JP, et al.]". Vienna.

Region Region Wien (Vienna)
  Country Austria
Organisations Organisation Marinomed Biotech AG (VSE: MARI)
  Organisation 2 Vienna Stock Exchange (VSE)
Products Product Marinosolv® technology platform
  Product 2 Carragelose®
Index term Index term Marinomed–SEVERAL: investment, 201811–201901 IPO €19.5m+€2.925m with 260k+39k new bearer shares at €75/share
Persons Person Grassauer, Andreas (Marinomed Biotechnologie GmbH 201307 CEO)
  Person 2 Schmidt, Pascal (Marinomed 201808– CFO before Raymond James Financial + Mummert & Co + Infineon Ventures)

Record changed: 2023-06-05


Picture EBD Group Bio-Europe Spring 2024 Barcelona 650x200px

More documents for Marinomed Biotech AG (VSE: MARI)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Stier Group MIXiii Lifescience Healthtech Conference 650x300px

» top